Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients ...Middle East

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., March 28, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline...

Read More Details
Finally We wish PressBee provided you with enough information of ( Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients )

Also on site :

• Reform MP James McMurdock suspends himself from party over ‘business propriety during pandemic’
• Disturbed’s David Draiman Met with Some Boos at Final Black Sabbath Concert
• Police investigation underway on Boardman Street near Monroe Avenue